<SEC-DOCUMENT>0001839882-23-020792.txt : 20230807
<SEC-HEADER>0001839882-23-020792.hdr.sgml : 20230807
<ACCEPTANCE-DATETIME>20230807190144
ACCESSION NUMBER:		0001839882-23-020792
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230807
DATE AS OF CHANGE:		20230807

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Progyny, Inc.
		CENTRAL INDEX KEY:			0001551306
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
		IRS NUMBER:				272220139
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-39100
		FILM NUMBER:		231148901

	BUSINESS ADDRESS:	
		STREET 1:		1359 BROADWAY
		STREET 2:		2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018
		BUSINESS PHONE:		212-888-3124

	MAIL ADDRESS:	
		STREET 1:		1359 BROADWAY
		STREET 2:		2ND FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10018

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Auxogyn, Inc.
		DATE OF NAME CHANGE:	20150318

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Auxogyn Inc
		DATE OF NAME CHANGE:	20120601

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TPG Biotechnology Partners III, L.P.
		CENTRAL INDEX KEY:			0001973071
		IRS NUMBER:				262171974
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		301 COMMERCE STREET
		STREET 2:		SUITE 3300
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
		BUSINESS PHONE:		(817)871-4000

	MAIL ADDRESS:	
		STREET 1:		301 COMMERCE STREET
		STREET 2:		SUITE 3300
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76102
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: TPG Biotechnology Partners III, L.P. -->
          <cik>0001973071</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>


    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001551306</issuerCik>
      <issuerName>Progyny, Inc.</issuerName>
      <secFileNumber>001-39100</secFileNumber>
      <issuerAddress>
        <com:street1>1359 Broadway</com:street1>
        <com:city>New York</com:city>
        <com:stateOrCountry>NY</com:stateOrCountry>
        <com:zipCode>10018</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>212-888-3124</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>TPG Biotechnology Partners III, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Stockholder</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BofA Securities, Inc.</name>
        <address>
          <com:street1>One Bryant Park</com:street1>
          <com:street2>5th Floor</com:street2>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10036</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2900000</noOfUnitsSold>
      <aggregateMarketValue>124410000.00</aggregateMarketValue>
      <noOfUnitsOutstanding>95406381</noOfUnitsOutstanding>
      <approxSaleDate>08/07/2023</approxSaleDate>
      <securitiesExchangeName>NASDAQGS</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock, $0.0001 par value per share</securitiesClassTitle>
      <acquiredDate>10/29/2019</acquiredDate>
      <natureOfAcquisitionTransaction>The shares of Common Stock reported herein were originally acquired by Seller on October 29, 2019 upon the automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>18905943</amountOfSecuritiesAcquired>
      <paymentDate>10/29/2019</paymentDate>
      <natureOfPayment>Automatic conversion of shares of Preferred Stock of the Issuer into shares of Common Stock.</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>08/07/2023</noticeDate>
      <signature>/s/ Ken Murphy</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
